- Short-term treatment of insomnia.
- Sedation in premedication before surgical or diagnostic procedures.
Milam
IM/IV Injection
Generic Name
Midazolam
Strength
15 mg/3 ml
Manufacturer
Eskayef Pharmaceuticals Ltd.
Unit Price
3 ml ampoule: ৳ 120.00
🔹 Indications
Milam is indicated in-
🔹 Pharmacology
The actions of benzodiazepines such as midazolam are mediated through the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), which is one of the major inhibitory neurotransmitters in the central nervous system. Benzodiazepines increase the activity of GABA, thereby producing a sedating effect, relaxing skeletal muscles, and inducing sleep, anesthesia, and amnesia. Benzodiazepines bind to the benzodiazepine site on GABA-A receptors, which potentiates the effects of GABA by increasing the frequency of chloride channel opening. These receptors have been identified in different body tissues including the heart and skeletal muscle, although mainly appear to be present in the central nervous system.
🔹 Dosage & Administration
Oral dosage:
- For adults: 7.5-15 mg daily.
- In elderly and debilitated patients: The recommended dose is 7.5 mg.
- In premedication: 15 mg of Midazolam should be given 30-60 minutes before the procedure.
- Endoscopic or Cardiovascular Procedures: In healthy adults, the initial dose is approximately 2.5 mg. In cases of severe illness and in elderly patients, the initial dose must be reduced to 1 to 1.5 mg.
- Induction of Anesthesia: The dose is 10-15 mg.
- Adult: 0.07-0.1 mg/kg body weight. The usual dose is about 5 mg.
- Children: 0.15-0.20 mg/kg
- Elderly and debilitated patients: 0.025-0.05 mg/kg
- For preoperative sedation: Rectal administration of the ampoule solution (0.35-0.45 mg/kg) 20-30 min. before induction of general anesthesia.
🔹 Interaction
Milam can enhance the central sedative effect of neuroleptics, tranquillizers, antidepressants, sleep-inducing drugs, analgesics, anaesthetics, antipsychotics, anxiolytics, antiepileptic drugs and sedative antihistamines.
🔹 Contraindications
Midazolam must not be given to patients with severe respiratory insufficiency, severe hepatic insufficiency, myasthenia gravis, sleep apnea syndrome and with known hypersensitivity to benzodiazepines or to any component of the product
🔹 Side Effects
At the start of therapy, drowsiness during daytime, confusion, fatigue, headache and muscle weakness may occur which usually disappear with repeated administration. Following parenteral (IV or IM) administration of Milam, fluctuations in vital signs have been noted including respiratory depression, apnea, variations in blood pressure and pulse rate.
🔹 Pregnancy & Lactation
Midazolam should be avoided during pregnancy unless there is no safer alternative. Since Midazolam passes into breast milk, it should not be administered to breast-feeding mothers.
🔹 Precautions & Warnings
Milam IV should be administered very slowly.
🔹 Storage Conditions
Protect from light and moisture, store in cool and dry place. Keep out of the reach of children.
🔍 People also search for
Milam
Milam IM/IV Injection used for
Milam side effects
Milam price
Milam dose
Milam IM/IV Injection uses
Is Milam safe
Milam dosage
Milam alternative
Milam Bangladesh
Midazolam
Midazolam price Bangladesh
IM/IV Injection price Bangladesh
Eskayef Pharmaceuticals Ltd.
medicine bd
Milam 15 mg/3 ml
Milam 15 mg/3 ml price
💡 Frequently Asked Questions
Milam is indicated in-
Short-term treatment of insomnia.
Sedation in premedication before surgical or diagnostic procedures.
Oral dosage:
For adults: 7.5-15 mg daily.
In elderly and debilitated patients: The recommended dose is 7.5 mg.
In premedication: 15 mg of Midazolam should be given 30-60 minutes before the procedure.
Intravenous administration:
Endoscopi...
At the start of therapy, drowsiness during daytime, confusion, fatigue, headache and muscle weakness may occur which usually disappear with repeated administration. Following parenteral (IV or IM) administration of Milam, fluctuations in vital signs...
User Reviews
⭐
No reviews yet!
Be the first to share your experience.